Posted in | News | Nanomedicine | Nanobusiness

zNose from Electronic Sensor Technology Provides Early Detection

Menssana Research, Inc. at Fort Lee in New Jersey has placed an additional order with Electronic Sensor Technology (EST) (OTCBB:ESNR), a leading provider of innovative homeland security, environmental and healthcare solutions.

Dr. Michael Phillips, a medical innovator who uses breath analysis to screen for pulmonary diseases, founded Menssana Research. He has utilized the ultra-fast zNose® vapor analyzer to analyze breath samples for biomarkers for lung cancer, breast cancer, heart transplant rejection and pulmonary tuberculosis (TB). EST believes that the pioneering work of Dr. Phillips in this field of pre-screening will save many lives through early detection.

Dr. Teong Lim, CEO of EST, stated that: “EST is very excited to work with Menssana Research on this important humanitarian effort. We look forward to continuing this rewarding work.”

For more information about Menssana Research and Dr. Phillips’ publications, please visit the website:

Founded in 1995, Electronic Sensor Technology has developed and patented a chemical vapor analysis process with applications for the homeland security, environment and healthcare markets.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type